Editorial Comment to Combination therapy with paclitaxel and gemcitabine after platinum‐based chemotherapy in patients with advanced urothelial cancer
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Urology"
DOI: 10.1111/iju.14634
Abstract: The medical treatment paradigm for advanced urothelial cancer (UC) has been changing dramatically since the introduction of immune checkpoint inhibitors. Currently, the gemcitabine/cisplatin regimen and pembrolizumab is widely used as standard first-line and second-line therapy,… read more here.
Keywords: chemotherapy; combination; paclitaxel gemcitabine; treatment ... See more keywords
Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.251
Abstract: 251 Background: Combination chemotherapy with nab-paclitaxel/gemcitabine is a standard of care option in metastatic pancreatic cancer management with increasing use due to an improvement in median overall survival of 1.8 months compared to gemcitabine alone.… read more here.
Keywords: chemotherapy; paclitaxel gemcitabine; metastatic pancreatic; cancer ... See more keywords
Risk factors for severe neutropenia among pancreatic cancer patients receiving nab-paclitaxel and gemcitabine combination therapy.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.684
Abstract: 684Background: Albumin-bound paclitaxel (nab-paclitaxel) and gemcitabine combination therapy (GnP therapy) significantly extends overall survival in patients with metastatic pancreatic cancer, comp... read more here.
Keywords: paclitaxel gemcitabine; nab paclitaxel; gemcitabine combination; therapy ... See more keywords